NabGen, Inc. is an NC based biotech company developing an antibody suppression platform with broad applications.
NabGen, Inc. has raised $3.0M in total funding. The most recent round was Grant. The last funding was announced in August 2025.
NabGen, Inc.'s investors include North Carolina Biotechnology Center.
NabGen, Inc. is headquartered in Durham, United States.
NabGen, Inc. is an NC based biotech company developing an antibody suppression platform with broad applications.
NabGen, Inc. is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NabGen, Inc. — Funding & Investors." VCBacked, August 15, 2025, https://www.vcbacked.co/company/nabgen-inc. Accessed November 14, 2026.
VCBacked. (2025). NabGen, Inc. — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/nabgen-inc
{{cite web |title=NabGen, Inc. — Funding & Investors |url=https://www.vcbacked.co/company/nabgen-inc |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at NabGen, Inc.? Request a listing update